Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Steven Thorpe to Sarcoma

This is a "connection" page, showing publications Steven Thorpe has written about Sarcoma.

 
Connection Strength
  
 
 
5.318
  
  1. Zeitlinger L, Chavez GM, Wilson MD, Darrow M, Canter RJ, Randall RL, Thorpe SW. Intraoperative Peripheral Frozen Margin Assessment in Soft Tissue Sarcoma. J Surg Oncol. 2025 Mar; 131(4):694-698.
    View in: PubMed
    Score: 0.762
  2. Zeitlinger L, Chavez GM, Darrow M, Canter RJ, Randall RL, Thorpe SW. Musculoskeletal Tumor Society Member Survey: Intra-Operative Peripheral Margins in Soft Tissue Sarcoma. J Surg Oncol. 2025 Mar; 131(4):699-702.
    View in: PubMed
    Score: 0.762
  3. Priester JI, Simister SK, Sario M, Choi J, Pina D, Theriault R, Bateni C, Ghasemiesfe A, Carr-Ascher J, Monjazeb AM, Canter RJ, Randall RL, Thorpe SW. Scrutinizing the use of contrasted chest CTs in extremity sarcoma staging and surveillance. J Surg Oncol. 2024 Mar; 129(3):523-530.
    View in: PubMed
    Score: 0.712
  4. Jawad MU, Pollock BH, Randall RL, Thorpe SW. Letter to Editor Referring to the Editorial by Istl et al. 'Good Bone Structure: A Call for Stronger Design and Methodology in Disparity Studies in Orthopedic Oncology' Discussing the Published Article: 'Non-Private Health Insurance Predicts Advanced Stage at Presentation and Amputation in Lower-Extremity High-Grade Bone Sarcoma: A National Cancer Database Study'. Ann Surg Oncol. 2022 11; 29(12):7351-7352.
    View in: PubMed
    Score: 0.649
  5. Freeland J, Muñoz M, O'Donnell E, Langerman J, Darrow M, Bergonio J, Suarez-Navarro J, Thorpe S, Canter R, Randall RL, Plath K, Carraway KL, Witte ON, Graeber TG, Carr-Ascher JR. Genetic Screen in a Preclinical Model of Sarcoma Development Defines Drivers and Therapeutic Vulnerabilities. Clin Cancer Res. 2024 Nov 01; 30(21):4957-4973.
    View in: PubMed
    Score: 0.190
  6. Garibay ER, Cruz SM, Judge SJ, Monjazeb AM, Thorpe SW, Murphy WJ, Lyu J, Chen S, Bateni CP, Canter RJ. Visceral fat area and subcutaneous fat area as measures of body composition in soft tissue sarcoma. J Surg Oncol. 2024 Sep; 130(3):543-551.
    View in: PubMed
    Score: 0.185
  7. Walker K, Simister SK, Carr-Ascher J, Monument MJ, Thorpe SW, Randall RL. Emerging innovations and advancements in the treatment of extremity and truncal soft tissue sarcomas. J Surg Oncol. 2024 Jan; 129(1):97-111.
    View in: PubMed
    Score: 0.178
  8. Jawad MU, Theriault RV, Thorpe SW, Randall RL. Socioeconomic disparities in musculoskeletal oncology. J Surg Oncol. 2023 Sep; 128(3):425-429.
    View in: PubMed
    Score: 0.175
  9. Cruz SM, Sholevar CJ, Judge SJ, Darrow MA, Iranpur KR, Farley LE, Lammers M, Razmara AM, Dunai C, Gingrich AA, Persky J, Mori H, Thorpe SW, Monjazeb AM, Murphy WJ, Canter RJ. Intratumoral NKp46+ natural killer cells are spatially distanced from T and MHC-I+ cells with prognostic implications in soft tissue sarcoma. Front Immunol. 2023; 14:1230534.
    View in: PubMed
    Score: 0.174
  10. Perry LM, Cruz SM, Kleber KT, Judge SJ, Darrow MA, Jones LB, Basmaci UN, Joshi N, Settles ML, Durbin-Johnson BP, Gingrich AA, Monjazeb AM, Carr-Ascher J, Thorpe SW, Murphy WJ, Eisen JA, Canter RJ. Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis. J Immunother Cancer. 2023 01; 11(1).
    View in: PubMed
    Score: 0.167
  11. Alvarez E, Spunt SL, Malogolowkin M, Li Q, Wun T, Brunson A, Thorpe S, Kreimer S, Keegan T. Treatment at Specialized Cancer Centers Is Associated with Improved Survival in Adolescent and Young Adults with Soft Tissue Sarcoma. J Adolesc Young Adult Oncol. 2022 08; 11(4):370-378.
    View in: PubMed
    Score: 0.156
  12. Salerno KE, Alektiar KM, Baldini EH, Bedi M, Bishop AJ, Bradfield L, Chung P, DeLaney TF, Folpe A, Kane JM, Li XA, Petersen I, Powell J, Stolten M, Thorpe S, Trent JC, Voermans M, Guadagnolo BA. Radiation Therapy for Treatment of Soft Tissue Sarcoma in Adults: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2021 Sep-Oct; 11(5):339-351.
    View in: PubMed
    Score: 0.151
  13. Jawad MU, Farhan S, Haffner MR, Le HV, Thorpe SW, Klineberg EO, Randall RL. Primary mobile vertebral column sarcomas: Prognostic factors vary by histologic subtypes. J Surg Oncol. 2021 Sep; 124(4):635-645.
    View in: PubMed
    Score: 0.150
  14. Judge SJ, Darrow MA, Thorpe SW, Gingrich AA, O'Donnell EF, Bellini AR, Sturgill IR, Vick LV, Dunai C, Stoffel KM, Lyu Y, Chen S, Cho M, Rebhun RB, Monjazeb AM, Murphy WJ, Canter RJ. Analysis of tumor-infiltrating NK and T cells highlights IL-15 stimulation and TIGIT blockade as a combination immunotherapy strategy for soft tissue sarcomas. J Immunother Cancer. 2020 11; 8(2).
    View in: PubMed
    Score: 0.144
  15. Phan EN, Thorpe SW, Wong FS, Saiz AM, Taylor SL, Canter RJ, Lenchik L, Randall RL, Boutin RD. Opportunistic muscle measurements on staging chest CT for extremity and truncal soft tissue sarcoma are associated with survival. J Surg Oncol. 2020 Oct; 122(5):869-876.
    View in: PubMed
    Score: 0.141
  16. Shah AC, Komperda KW, Mavanur AA, Thorpe SW, Weiss KR, Goodman MA. Overall survival and tumor recurrence after surgical resection for primary malignant chest wall tumors: a single-center, single-surgeon experience. J Orthop Surg (Hong Kong). 2019 May-Aug; 27(2):2309499019838296.
    View in: PubMed
    Score: 0.130
  17. Gingrich AA, Bateni SB, Monjazeb AM, Thorpe SW, Kirane AR, Bold RJ, Canter RJ. Extremity soft tissue sarcoma in the elderly: Are we overtreating or undertreating this potentially vulnerable patient population? J Surg Oncol. 2019 Jun; 119(8):1087-1098.
    View in: PubMed
    Score: 0.129
  18. Bateni SB, Gingrich AA, Jeon SY, Hoch JS, Thorpe SW, Kirane AR, Bold RJ, Canter RJ. Clinical Outcomes and Costs Following Unplanned Excisions of Soft Tissue Sarcomas in the Elderly. J Surg Res. 2019 07; 239:125-135.
    View in: PubMed
    Score: 0.128
  19. Yanagisawa M, Gingrich AA, Judge S, Li CS, Wang N, Thorpe SW, Kirane AR, Bold RJ, Monjazeb AM, Canter RJ. Serum C-reactive Protein and Neutrophil/Lymphocyte Ratio After Neoadjuvant Radiotherapy in Soft Tissue Sarcoma. Anticancer Res. 2018 03; 38(3):1491-1497.
    View in: PubMed
    Score: 0.120
  20. Gingrich AA, Bateni SB, Monjazeb AM, Darrow MA, Thorpe SW, Kirane AR, Bold RJ, Canter RJ. Neoadjuvant Radiotherapy is Associated with R0 Resection and Improved Survival for Patients with Extremity Soft Tissue Sarcoma Undergoing Surgery: A National Cancer Database Analysis. Ann Surg Oncol. 2017 Oct; 24(11):3252-3263.
    View in: PubMed
    Score: 0.115
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)